Hematological and hemorheological determinants of the six-minute walk test performance in children with sickle cell anemia. by Waltz, Xavier et al.
Hematological and hemorheological determinants of the
six-minute walk test performance in children with sickle
cell anemia.
Xavier Waltz, Marc Romana, Marie-Dominique Hardy-Dessources, Yann
Lamarre, Lydia Divialle-Doumdo, Marie Petras, Vanessa Tarer, Re´gine Hierso,
Kizzy-Clara Baltyde, Benoˆıt Tressie`res, et al.
To cite this version:
Xavier Waltz, Marc Romana, Marie-Dominique Hardy-Dessources, Yann Lamarre, Lydia
Divialle-Doumdo, et al.. Hematological and hemorheological determinants of the six-minute
walk test performance in children with sickle cell anemia.. PLoS ONE, Public Library of Sci-
ence, 2013, 8 (10), pp.e77830. <10.1371/journal.pone.0077830>. <inserm-00922110>
HAL Id: inserm-00922110
http://www.hal.inserm.fr/inserm-00922110
Submitted on 23 Dec 2013
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
Hematological and hemorheological Determinants of the
Six-Minute Walk Test Performance in Children with Sickle
Cell Anemia
Xavier Waltz1,2,3, Marc Romana1,3, Marie-Dominique Hardy-Dessources1,3, Yann Lamarre1,3, Lydia Divialle-
Doumdo4, Marie Petras4, Vanessa Tarer5, Régine Hierso1,3, Kizzy-Clara Baltyde1,3, Benoît Tressières6,
Marie-Laure Lalanne-Mistrih1,6, Fréderic Maillard7, Olivier Hue2, Maryse Etienne-Julan1,4,5, Philippe
Connes1,2,3,8*
1 UMR Inserm 665, Université des Antilles et de la Guyane, Pointe-à-Pitre, Guadeloupe, France, 2 Laboratoire ACTES (EA 3596), Département de Physiologie,
Université des Antilles et de la Guyane, Pointe-à-Pitre, Guadeloupe,  France, 3 Laboratory of Excellence GR-Ex “The red cell: from genesis to death”, PRES
Sorbonne Paris Cité, Paris, France, 4 Unité Transversale de la Drépanocytose, Centre Hospitalier et Universitaire de Pointe-à-Pitre, Pointe-à-Pitre,
 Guadeloupe, France, 5 Centre de référence maladies rares pour la drépanocytose aux Antilles-Guyane, Centre Hospitalier et Universitaire de Pointe-à-Pitre,
Pointe-à-Pitre, Guadeloupe, France, 6 CIC-EC 802 Inserm, Centre Hospitalier Universitaire de Pointe-à-Pitre, Pointe-à-Pitre,  Guadeloupe, France, 7 Service de
Pédiatrie du Centre Hospitalier et Universitaire de Pointe-à-Pitre, Pointe-à-Pitre, Guadeloupe, France, 8 Institut Universitaire de France, Paris, France
Abstract
The six-minute walk test is a well-established submaximal exercise reflecting the functional status and the clinical
severity of sickle cell patients. The aim of the present cross-sectional study was to investigate the biological
determinants of the six-minute walk test performance in children with sickle cell anemia. Hematological and
hemorheological parameters, pulmonary function and the six-minute walk test performance were determined in 42
children with sickle cell anemia at steady state. The performance during the six-minute walk test was normalized for
age, sex and height and expressed as percentage of the predicted six-minute walk distance. We showed that a high
level of anemia, a low fetal hemoglobin expression and low red blood cell deformability were independent predictors
of a low six-minute walk test performance. This study describes for the first time the impact of blood rheology in the
six-minute walk test performance in children with sickle cell anemia.
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Introduction
The six-minute walk test (6MWT) is a submaximal exercise
test used in several diseases, and more recently in patients
with sickle cell anemia (SCA), to determine the functional
status, physical fitness and the degree of clinical severity in this
disease [1]. Machado et al [2] previously reported that the
6MWT distance directly correlated with peak oxygen
consumption in SCA. Moreover, the 6MWT performance
inversely correlated with the severity of pulmonary
hypertension in SCA [3] and pulmonary hypertension therapy
improved walk distance [2]. So far, very few studies have
focused on the determinants of the 6MWT performance in
SCA.
SCA is characterized by severe hemorheological
abnormalities, which play a role in the pathophysiology of
several complications [4–10]. In isolated vessels or animals
models, a reduction in red blood cell (RBC) deformability and
abnormal RBC aggregation properties have been shown to
affect microcirculatory blood flow and tissue perfusion [11–14]..
Recently, associations between blood rheological alterations
and decreased tissue oxygenation, both at the muscle and
cerebral level, have been described in sickle cell patients
[15,16]. Based on these previous studies, one could suggest
that the degree of hemorheological abnormalities, in
association with the degree of anemia, could affect the 6MWT
performance in SCA population.
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The aim of the present study was to test the associations
between hemorheological/hematological abnormalities and the
performance during the 6MWT in children with SCA.
Methods
Patients
The study included 42 SCA (HbSS) children (8-17 years old)
at steady state: no blood transfusions in the previous three
months, absence of acute episodes (infection, vaso-occlusive
crises (VOC), acute chest syndrome (ACS), stroke, priapism,
splenic sequestration) at least one month before inclusion into
the study. None of the SCA children was under hydroxyurea
treatment.
Charts were retrospectively reviewed by three physicians to
recognize all ACS and VOC episodes from birth to the time of
blood sampling based on previously described criteria [8]. An
acute event was considered a VOC if the painful episode lasted
for more than four hours, the patient felt that the pain was
typical of that of vaso-occlusion, no other etiology of pain could
be identified by the physicians, and the patient was admitted to
the Accident and Emergency Pediatric Department to treat the
pain with parenteral opioids (with or without non-steroidal anti-
inflammatory drugs). ACS, splenic or hepatic sequestration or
exacerbations of chronic painful conditions such as avascular
necrosis or leg ulcer were not considered as painful VOC
episodes. ACS was defined as the appearance of a new
infiltrate on chest radiograph, associated with one or more
clinical symptoms such as chest pain, respiratory distress,
fever and cough. The rates of ACS and VOC were calculated
for each child by dividing the total number of ACS or painful
VOC episodes by the number of patient-years [8,17].
The study was conducted in accordance to the Declaration of
Helsinki and was approved by the Regional Ethics Committee
(CPP Sud/Ouest Outre Mer III, Bordeaux, France, registration
number: 2009-A00211-56). Children and their parents were
informed of the purpose and procedures of the study, and gave
written informed consent.
Hematological and hemorheological measurements
Blood was drawn by venipuncture into EDTA tubes and used
for measurements of hematological parameters as previously
described [8]. Serum lactate dehydrogenase and total bilirubin
concentrations were determined by standard biochemical
methods.
Hemorheological parameters were measured immediately
after sampling and after full re-oxygenation of the blood [18].
Blood viscosity was measured at native hematocrit (Brookfield
DVII+ cone-plate viscometer, CPE40-spindle, ≈25°C, 90 s-1).
RBC deformability was determined at 37°C at two shear
stresses (3 and 30 Pa) by ecktacytometry (LORCA, RR
Mechatronics, Hoorn, The Netherlands). As recommended by
the international guidelines in hemorheology [18], RBC
aggregation was determined at 37°C via syllectometry (i.e.,
laser backscatter versus time), (LORCA, RR Mechtronics,
Hoom, The Netherlands) and after adjustment of the hematocrit
to 40%. Hematocrit standardization was done by removing the
adequate volume of plasma after blood centrifugation [18]. The
RBC disaggregation threshold, i.e., the minimal shear rate
needed to prevent RBC aggregation or to breakdown existing
RBC aggregates, was determined using a re-iteration
procedure [19].
Six-minute walk Test (6MWT)
The 6MWT was conducted according to the guidelines of the
American Thoracic Society [20]. The percentage of predicted
distance was calculated according to the models of Geiger et al
[21] which takes into account the sex, height and age.
Hemoglobin oxygen saturation (SpO2) was obtained by finger
pulse oximetry (Sure Signs VS3 No. 3000, Philips Medical
System, Andover, MA, USA) before the 6MWT.
Pulmonary function tests
Pulmonary function tests were performed on the same day
as the blood sampling and the 6MWT (before), and included
forced expiratory volume in 1 second (FEV), forced vital
capacity (FVC) and FEV/FVC.
Statistics
All values were expressed as means ± SD. To identify
factors associated with the 6MWT performance, we used
parametric or non-parametric correlations (Pearson or
Spearman, respectively) between the percentage of predicted
distance and the others physiological/biological/clinical
parameters. Then, all variables at p < 0.20 were included in a
multivariate linear regression models to identify the covariates
independently associated with the percentage of predicted
distance (i.e., 6MWT performance). Significance level was
defined as p < 0.05. Analyses were conducted using SPSS (v.
20, IBM SPSS Statistics, Chicago, IL).
Results
The characteristics of SCA children and the results obtained
for the correlations between hematological, hemorheological or
clinical parameters and the percentage of predicted distance
are shown in Table 1.
Univariate analyses
We observed significant correlations between the percentage
of predicted distance and the level of fetal hemoglobin,
platelets count, hemoglobin level, hematocrit and the RBC
disaggregation threshold. The mean arterial blood pressure,
leukocytes count, RBC count, lactate dehydrogenase level,
RBC deformability at 3 Pa and 30 Pa were not significantly
correlated with the percentage of predicted distance, but had a
p < 0.20 by linear correlation. Neither the clinical complications
studied, i.e., VOC and ACS, nor the pulmonary function tests
were correlated with the percentage of the predicted distance.
Multivariate analyses
To identify the determinants of the 6MWT performance in
children with SCA, a multivariate linear regression model was
performed. This model included the percentage of predicted
distance as dependent variable and fetal hemoglobin, platelets
Six-Minute-Walk Test and Blood Rheology
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count, hematocrit, white blood cell count, lactate
dehydrogenase, mean arterial blood pressure, RBC
deformability at 3 Pa and RBC disaggregation threshold as
Table 1. Sickle cell children characteristics and correlation
between hematological, hemorheological, and clinical






predicted distance p value
Sex ratio (M/F) 22/20 - -
α-thalassemia (%) 35.7 - -
Age (yrs.) 11.7 ± 2.4 - -
Walked distance (m) 491 ± 64 - -
Percentage of predicted
distance (%) 74.5 ± 10.0 - -
BMI (Kg.m-2) 16.8 ± 2.3 r = - 0.03 NS
Heart rate at rest (beat/
min) 82 ± 11 r = 0.16 NS
MAP (mmHg) § 79 ± 7 r = - 0.26 0.1
SpO2 (%) 97.7 ± 2.5 ρ = 0.07 NS
Fetal hemoglobin (%) § 8.2 ± 6.4 r = 0.58 < 0.001
Leukocytes (109.l-1) § 10.7 ± 2.6 r = - 0.22 0.18
Red blood cells (1012.l-1)
$ 2.9 ± 0.7 r = 0.27 0.10
Platelets (109.l-1) § 452 ± 125 r = 0.31 < 0.05
Hemoglobin (g.dl-1) $ 8.0 ± 1.3 r = 0.46 < 0.01
Hematocrit (%) § 24.7 ± 4.5 r = 0.35 < 0.05
Mean cell volume (fl) 79.9 ± 7.7 r = 0.13 NS
MCH (pg) 27.5 ± 3.0 ρ = 0.18 NS
Reticulocytes (%) 10.7 ± 5.9 ρ = - 0.08 NS
Lactate dehydrogenase
(IU) § 578 ± 170 ρ = - 0.31 0.06
Total bilirubin (μmol.l-1) 64.2 ± 43.7 ρ = - 0.15 NS
Blood viscosity
(mPa.s-1) 7.0 ± 2.1 r = 0.13 NS
RBC deformability at 3
Pa (a.u) § 0.16 ± 0.06 r = 0.29 0.07
RBC deformability at 30
Pa (a.u) $ 0.39 ± 0.11 r = 0.27 0.09
RBC aggregation index
(%) 49.3 ± 10.4 ρ = - 0.17 NS
RBC disaggregation
threshold (s-1) § 278 ± 102 r = - 0.43 < 0.01
VOC rate 0.31 ± 0.46 ρ = 0.06 NS
ACS rate 0.09 ± 0.16 ρ = - 0.07 NS
FEV (l) 1.82 ± 0.61 r = - 0.16 NS
FVC (l) 2.01 ± 0.66 r = - 0.16 NS
FEV/FVC (%) 91.4 ± 8.6 r = 0.13 NS
Values represent mean ± SD. MAP, mean arterial blood pressure; BMI, Body Mass
Index; SpO2, arterial hemoglobin oxygen saturation; MCH, mean cell hemoglobin;
VOC, vaso-occlusive crises; ACS, acute chest syndrome; FEV, forced expiratory
volume in 1 second; FVC, forced vital capacity; § covariates included in the
multivariate analysis. $ covariates discarded from the multivariate analysis to avoid
co-linearity.
doi: 10.1371/journal.pone.0077830.t001
covariates. RBC count, hemoglobin level, and RBC
deformability at 30 Pa were not included into the model to
avoid co-linearity effects with hematocrit and RBC deformability
at 3 Pa.
The overall model was significant (R² = 0.704, df = 8, p <
0.001). The Hct (beta = 1.12; 95% CI 0.33 to 1.90; p < 0.01),
fetal hemoglobin level (beta = 1.02; 95% CI 0.52 to 1.53; p <
0.001) and RBC deformability (beta = -0.76; 95% CI -1.46 to
-0.06; p < 0.05) were significantly associated with the
percentage of predicted distance. Because two SCA patients
were asthmatic and under medication, the univariate and
multivariate analyses were also done after removing these two
children but the results were similar (data not shown).
Discussion
This is the first study showing an implication of blood
rheology on the six-minute walk test performance in children
with SCA. We showed that a low level of RBC deformability, a
high level of anemia and a low fetal hemoglobin level were
independent predictors of a reduced 6MWT performance (i.e.,
low percentage of predicted 6-min walk distance) in SCA
children.
This work is the first one to show an independent association
between RBC deformability and the 6MWT performance in
SCA children. This is in agreement with a previous study
performed in world-class endurance athletes, which reported
an association between RBC deformability and aerobic
physical fitness [22]. Ours results support the fact that having
higher RBC deformability contributes to a greater 6MWT
distance in SCA children. A reduction of RBC deformability
increases blood flow resistance into the microcirculation [6] and
affects tissue oxygenation [11,15] because RBC with poor
deformability cannot easily deform to enter into and flow
through the microcirculation and bring oxygen to tissues.
Based on these results, it is tempting to hypothesize that
medication increasing RBC deformability, such as hydroxyurea,
could increase physical capacity in SCA children. The results
from Hackney et al [23] support this hypothesis. Moreover,
RBC deformability in SCA patients is dependant on the quantity
of hemoglobin S into RBCs and higher level of fetal hemoglobin
increases the delay time of hemoglobin S polymerization, thus
partially inhibiting RBC sickling [24]. Our results also suggest
that fetal hemoglobin level plays a key role in exercise capacity
in SCA population.
We recently reported that despite reduced hemoglobin
concentration and hematocrit level in SCA patients, the local
resting muscle oxygen consumption is comparable between
SCA patients and healthy subjects because the local resting
microvascular blood flow is increased in the former population
[25]. Although the hemodynamic compensation for chronic
anemia may be sufficient to normalize muscle oxygen
consumption at rest, this is not the case during exercise where
the needs for oxygen gradually increase with the intensity. The
transition from aerobic to anaerobic metabolism appears earlier
during exercise in SCA patients in comparison with healthy
subjects [26,27]. Indeed, it is not surprising to observe that
hematocrit level was independently associated with the
Six-Minute-Walk Test and Blood Rheology
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percentage of predicted distance in SCA children, which is in
accordance with the previous study of Liem et al [28] The key
role of hemoglobin and hematocrit levels in exercise capacity in
SCA patients is further supported by studies showing an
increase of exercise performance in SCA patients after
transfusion [29].
The six-minute walk test is a useful assessor of submaximal
exercise ability in patients with SCA [2,3] and has been shown
to reflect a certain degree of clinical severity; i.e., mainly in the
context of pulmonary hypertension [3]. Because SCA is
characterized by abnormalities in lung function, one could
expect a contribution of lung dysfunction in the decrease of the
6-min walk distance. However, in agreement with the study of
Caboot et al [30], our study does not support this hypothesis.
To further extend previous studies on the associations between
clinical severity and the exercise capacity in SCA patients, we
also tested the associations between the 6-min walk distance
and the rate of VOC and ACS but our results failed to
demonstrate any association.
In conclusion, our study demonstrated for the first time that
the level of fetal hemoglobin and RBC deformability are
predictors of the six-minute-walk test performance in SCA
children, and confirmed that the performance during such an
exercise is affected by the degree of anemia. The association
between the level of fetal hemoglobin and the six-minute-walk
test performance suggests that hydroxyurea therapy could be
very beneficial for the exercise capacity of SCA patients. This
should be considered as another motivation for treating the
most severe SCA patients with this therapy. Further studies are
needed to test the effects of hydroxyurea on exercise capacity
accurately. Moreover, the effects of asthma or exercise-
induced asthma were not specifically addressed in this study:
future studies should focus on this issue. Finally, a larger study
is needed to test the effect of gender on the six-minute-walk
test performance.
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